{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:46:31Z","timestamp":1781696791793,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":2877,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13311-015-0379-1","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T09:39:43Z","timestamp":1439458783000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Distinct Region in Erythropoietin that Induces Immuno\/Inflammatory Modulation and Tissue Protection"],"prefix":"10.1016","volume":"12","author":[{"given":"RuiRong","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0379-1_bib1","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood\u2013brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0379-1_bib2","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0379-1_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/cs1030275","article-title":"Erythropoietin and the brain: from neurodevelopment to neuroprotection","volume":"103","author":"Buemi","year":"2002","journal-title":"Clin Sci"},{"key":"10.1007\/s13311-015-0379-1_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s004060170038","article-title":"Erythropoietin\u2014a novel concept for neuroprotection","volume":"251","author":"Siren","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1007\/s13311-015-0379-1_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jnen\/62.3.228","article-title":"The pleiotropic effects of erythropoietin in the central nervous system","volume":"62","author":"Buemi","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1007\/s13311-015-0379-1_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.bjp.0707285","article-title":"Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia","volume":"151","author":"Wang","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0379-1_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.20274","article-title":"Beneficial effect of erythropoietin on experimental allergic encephalomyelitis","volume":"56","author":"Li","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-015-0379-1_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1227\/01.NEU.0000347475.73347.5F","article-title":"Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage","volume":"65","author":"Grasso","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-015-0379-1_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3171\/2011.3.JNS101721","article-title":"Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats","volume":"115","author":"Meng","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-015-0379-1_bib10","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0379-1_bib11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1523\/JNEUROSCI.4480-05.2006","article-title":"A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery","volume":"26","author":"Tsai","year":"2006","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0379-1_bib12","doi-asserted-by":"crossref","unstructured":"Yuan RR, Maeda Y, Li WP, et al. Erythropoietin: a potent inducer of peripheral immuno\/inflammatory modulation in autoimmune EAE. PLoS One 2008:3.","DOI":"10.1371\/journal.pone.0001924"},{"key":"10.1007\/s13311-015-0379-1_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.13-S3-11","article-title":"Venous thromboembolic events and erythropoiesis-stimulating agents: An update","volume":"13","author":"Dicato","year":"2008","journal-title":"Oncologist"},{"key":"10.1007\/s13311-015-0379-1_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMoa071533","article-title":"Efficacy and safety of epoetin alfa in critically ill patients","volume":"357","author":"Corwin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-015-0379-1_bib15","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"key":"10.1007\/s13311-015-0379-1_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(85)90006-1","article-title":"Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein","volume":"69","author":"Yoshimura","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-015-0379-1_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.136.1.157","article-title":"The immunopathology of chronic experimental allergic encephalomyelitis induced in rabbits with bovine proteolipid protein","volume":"136","author":"Sobel","year":"1986","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.142.5.1523","article-title":"Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice","volume":"142","author":"Tuohy","year":"1989","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4049\/jimmunol.149.3.783","article-title":"Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice","volume":"149","author":"Greer","year":"1992","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(99)00081-8","article-title":"Pathogenesis of tissue injury in MS lesions","volume":"98","author":"Trapp","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-015-0379-1_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-015-0379-1_bib22","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","article-title":"High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay","volume":"103","author":"Crawford","year":"2004","journal-title":"Blood"},{"key":"10.1007\/s13311-015-0379-1_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(03)00210-8","article-title":"Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4\u2013\/\u2013 and CD8\u2013\/\u2013 DBA\/1 mice defines qualitative roles of different T cell subsets","volume":"141","author":"Abdul-Majid","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-015-0379-1_bib24","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1182\/blood-2002-10-3309","article-title":"CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1","volume":"101","author":"Battistini","year":"2003","journal-title":"Blood"},{"key":"10.1007\/s13311-015-0379-1_bib25","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains","volume":"166","author":"Bebo","year":"2001","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1529\/biophysj.104.040907","article-title":"Structure of A beta(25-35) peptide in different environments","volume":"87","author":"Shanmugam","year":"2004","journal-title":"Biophys J"},{"key":"10.1007\/s13311-015-0379-1_bib27","doi-asserted-by":"crossref","unstructured":"Bohlius J, Schmidlin K, Brillant C, et al. Erythropoietin or Darbepoetin for patients with cancer\u2014meta-analysis based on individual patient data. Cochrane Database of Syst Rev 2009;CD007303.","DOI":"10.1002\/14651858.CD007303.pub2"},{"key":"10.1007\/s13311-015-0379-1_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1179\/174313208X353703","article-title":"Erythropoietin improves brain mitochondrial function in rats after traumatic brain injury","volume":"31","author":"Xiong","year":"2009","journal-title":"Neurol Res"},{"key":"10.1007\/s13311-015-0379-1_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2010.04238.x","article-title":"Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis","volume":"162","author":"Chen","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","article-title":"Erythropoietin treatment improves neurological functional recovery in EAE mice","volume":"1034","author":"Zhang","year":"2005","journal-title":"Brain Res"},{"key":"10.1007\/s13311-015-0379-1_bib31","doi-asserted-by":"crossref","first-page":"22839","DOI":"10.1016\/S0021-9258(17)31721-0","article-title":"Erythropoietin structure\u2013function relationships. Identification of functionally important domains","volume":"269","author":"Wen","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-015-0379-1_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2119\/molmed.2010.00235","article-title":"A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage","volume":"17","author":"Ahmet","year":"2011","journal-title":"Mol Med"},{"key":"10.1007\/s13311-015-0379-1_bib33","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo","volume":"100","author":"Erbayraktar","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-015-0379-1_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1007\/s13311-015-0379-1_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000014403","article-title":"Impaired biological activity of erythropoietin by cyanate carbamylation","volume":"18","author":"Mun","year":"2000","journal-title":"Blood Purif"},{"key":"10.1007\/s13311-015-0379-1_bib36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/CCM.0B013E3181644343","article-title":"Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury","volume":"36","author":"Adembri","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-015-0379-1_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2005.10.016","article-title":"Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis","volume":"172","author":"Savino","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1007\/s13311-015-0379-1_bib38","first-page":"235","article-title":"Identification of a neurotrophic sequence in erythropoietin","volume":"1","author":"Campana","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1007\/s13311-015-0379-1_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.194.5.669","article-title":"A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis","volume":"194","author":"Huseby","year":"2001","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-015-0379-1_bib40","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.4049\/jimmunol.166.12.7579","article-title":"Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL\/6 mice","volume":"166","author":"Sun","year":"2001","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/intimm\/dxg023","article-title":"Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules","volume":"15","author":"Sun","year":"2003","journal-title":"Int Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1007\/s13311-015-0379-1_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jnr.20201","article-title":"T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice","volume":"77","author":"Chou","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-015-0379-1_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.05.001","article-title":"Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies","volume":"23","author":"Montero","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1007\/s13311-015-0379-1_bib45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/glia.20046","article-title":"Astrocyte-induced regulatory T cells mitigate CNS autoimmunity","volume":"47","author":"Trajkovic","year":"2004","journal-title":"Glia"},{"key":"10.1007\/s13311-015-0379-1_bib46","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.172.4.1991","article-title":"Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis","volume":"172","author":"Faunce","year":"2004","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9440(10)63126-4","article-title":"Bystander CD8 T-cell-mediated demyelination is interferon-gamma-dependent in a coronavirus model of multiple sclerosis","volume":"164","author":"Dandekar","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1007\/s13311-015-0379-1_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nbd.2004.12.017","article-title":"EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses","volume":"19","author":"Linker","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-015-0379-1_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/eji.200425660","article-title":"Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis","volume":"35","author":"Ford","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/08830180500379655","article-title":"Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides","volume":"24","author":"Fontoura","year":"2005","journal-title":"Int Rev Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4049\/jimmunol.1203201","article-title":"Th17 cells induce Th1-polarizing monocyte-derived dendritic cells","volume":"191","author":"Davidson","year":"2013","journal-title":"J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib52","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/eji.200839179","article-title":"Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE","volume":"39","author":"Isaksson","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1007\/s13311-015-0379-1_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2010.03.004","article-title":"Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis","volume":"32","author":"Kang","year":"2010","journal-title":"Immunity"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0379-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0379-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:41:40Z","timestamp":1761806500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1878747923008176"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0379-1","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Distinct Region in Erythropoietin that Induces Immuno\/Inflammatory Modulation and Tissue Protection","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0379-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0384-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}